DIALYSIS · CCN 052794

DaVita USC Kidney Center

Los Angeles, CA 90033

DialysisProfitDaVita
$17.3M
TOTAL REVENUE
22.0%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$17.3M
Total costs
$13.5M
Operating income (rev − costs)
$3.8M
Operating margin
22.0%
Total charges
$17.2M
Total treatments
46,540
Dialysis stations
56

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8195—
Fistula Rate
DFC_FISTULA_RATE
64.9280—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.57131—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
4——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
143.2174—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.23——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
20280—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
18.5665—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
22347—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
24.4162—
Standardized ED Visits Ratio
DFC_SEDR
0.79137—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
22.4117—